newsfilter
← Latest News
Business Wire·

Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference

  • Vir Biotechnology CEO Marianne De Backer will attend the Bank of America Securities 2026 Healthcare Conference fireside chat on Tuesday, May 12.
  • The event is scheduled for 4:20 p.m. PT / 7:20 p.m. ET in Las Vegas, Nevada.
  • A live webcast will be available at investors.vir.bio \& archived for 30 days.
  • Vir is a clinical-stage biopharmaceutical company developing treatments for infectious diseases \& cancer.
  • The company's clinical portfolio includes programs for chronic hepatitis delta \& PRO-XTEN dual-masked T-cell engagers for solid tumors.
  • Vir holds exclusive rights to the PRO-XTEN masking platform for oncology \& infectious disease applications.